# Targeting mitochondrial dysfunction with elamipretide.

> PubMed lists PMID 35037146 in Heart failure reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-01-17 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-35037146-elamipretide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-07-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-35037146-elamipretide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-35037146-elamipretide-v1.json
- Content SHA-256: `697452ca868db5d967601754a4dd4749c49c866a1ee1c712f702c05a5af7668c`

## Claims and source pins

### Headline

Targeting mitochondrial dysfunction with elamipretide. ([`pubmed-observation-pmid-35037146-2025-07-28-d0cd8ca6d86e`](#source-pubmed-observation-pmid-35037146-2025-07-28-d0cd8ca6d86e))

### Summary

PubMed lists PMID 35037146 in Heart failure reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-01-17 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35037146-2025-07-28-d0cd8ca6d86e`](#source-pubmed-observation-pmid-35037146-2025-07-28-d0cd8ca6d86e))

### Paragraph 1

PubMed lists PMID 35037146 in Heart failure reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-01-17 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35037146-2025-07-28-d0cd8ca6d86e`](#source-pubmed-observation-pmid-35037146-2025-07-28-d0cd8ca6d86e))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-35037146-2025-07-28-d0cd8ca6d86e`](#source-pubmed-observation-pmid-35037146-2025-07-28-d0cd8ca6d86e))

## Sources

<a id="source-pubmed-observation-pmid-35037146-2025-07-28-d0cd8ca6d86e"></a>
- **Targeting mitochondrial dysfunction with elamipretide. · retained source version 1:2025-07-28:current:d0cd8ca6d86eb3d7a9c74d20b8872ca6cc919ff747b82d0e549548f5293b20aa** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/35037146/) (`pubmed-observation-pmid-35037146-2025-07-28-d0cd8ca6d86e`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Targeting mitochondrial dysfunction with elamipretide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-35037146-elamipretide-v1.json SHA-256: 697452ca868db5d967601754a4dd4749c49c866a1ee1c712f702c05a5af7668c.